Antibody-Mimicking Nanocluster Ameliorates Osteoporosis in Preclinical Model
ACS Nano Medicine · 11.11.2026 · 1 (10) · 2716-2729
DOI: 10.1021/acsnanomed.6c00201 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano Medicine, online erschienen am 06.10.2026. Verfasst von Qing Yuan und 12 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Osteoporosis occurs due to the synergistic effect of increased bone resorption and decreased bone formation. However, a therapeutic approach that can simultaneously inhibit osteoclastic resorption and promote osteogenic activity directly is still lacking. Growing evidence demonstrates the I-kappaB kinase beta (IKKβ)-mediated NF-κB activation is a common crucial regulator in differentiation of both osteoclasts and osteoblasts. Herein, we screened a peptide-coated gold nanocluster (GA) and further disclosed that the optimized GA works like an antibody to block IKKβ activation well. The GA can simultaneously inhibit IKKβ-mediated osteoclastogenesis and enhances osteoblastic mineralization in vitro and effectively ameliorates osteoporosis in a preclinical model in a safe manner. Compared with first-line antiresorptive alendronate (ALN, suppress bone resorption only), GA significantly promotes bone formation and improves the quality of bone microarchitecture in vivo. These data suggest that antibody-like GAs hold great potential in osteoporosis therapy.
Förderung
- Ministry of Science and Technology of the People's Republic of China
- National Natural Science Foundation of China
Zitieren
APA
Yuan, Q., Li, Q., Zhang, Z., Xia, D., Dang, H., Wang, L., Niu, W., Chen, Z., Gao, L., Zhao, L., Cao, K., Gao, X., & Gao, X. (2026). Antibody-Mimicking Nanocluster Ameliorates Osteoporosis in Preclinical Model. ACS Nano Medicine, 1(10), 2716-2729. https://doi.org/10.1021/acsnanomed.6c00201
Vancouver
Yuan Q, Li Q, Zhang Z, Xia D, Dang H, Wang L, et al. Antibody-Mimicking Nanocluster Ameliorates Osteoporosis in Preclinical Model. ACS Nano Medicine. 2026;1(10):2716-2729. doi:10.1021/acsnanomed.6c00201
BibTeX
@article{Yuan2026,
author = {Yuan, Qing and Li, Qiao-Zhi and Zhang, Zhichao and Xia, Dongfang and Dang, Haoran and Wang, Liming and Niu, Wenchao and Chen, Zhen and Gao, Liang and Zhao, Lina and Cao, Kai and Gao, Xingfa and Gao, Xueyun},
title = {Antibody-Mimicking Nanocluster Ameliorates Osteoporosis in Preclinical Model},
journal = {ACS Nano Medicine},
year = {2026},
volume = {1},
number = {10},
pages = {2716--2729},
doi = {10.1021/acsnanomed.6c00201}
}
EUVIMED